Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1437515
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1437515
Morphine Drugs Market, By Dosage Form, By Application, By Distribution Channel, By End Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
PUBLISHED:
PAGES: 287 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
Morphine Drugs Market size was valued at USD 22,870 Million in 2023, expanding at a CAGR of 4.5% from 2024 to 2032.
When other medications are ineffective or intolerable for the patient, morphine is used to treat moderate to severe pain. An opioid drug called morphine is used to treat pain, either chronic or acute, and it typically works quite well. As an opiate (narcotic) analgesic, morphine is a member of this class of drugs. Through its binding to the mu-opioid receptors in the central nervous system (CNS) and peripheral nervous system (PNS), morphine alters the way the brain and nervous system react to pain.
Morphine Drugs Market- Market Dynamics
Rising geriatric population along with chronic illness drives the market growth
Over the projection period, the demand for different opioid medications like morphine is predicted to rise due to the growing elderly population and the rising prevalence of chronic illnesses. Chronic pain and osteoarthritis diseases are more common in the elderly population. In May 2021, the MDPI published a report indicating that chronic pain was a significant problem impacting over 50% of the elderly population. In addition, it is predicted that the rising prevalence of arthritis would increase demand for painkillers. The Arthritis Society Canada estimates that 50% of those over 65 suffer from arthritis. Thus, during the course of the forecast period, the growing number of people experiencing chronic pain worldwide is anticipated to propel the morphine market.
Morphine Drugs Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.5% over the forecast period (2024-2032)
Based on dosage form segmentation, injection was predicted to show maximum market share in the year 2023
Based on application segmentation, pain management was the leading type in 2023
Based on region, North America was the leading revenue generator in 2023
Morphine Drugs Market- Segmentation Analysis:
The Global Morphine Drugs Market is segmented based on Dosage Form, Application, Distribution Channel, End Use, and Region.
The market is divided into three categories based on dosage form: Oral, Injection and Others. Injection sector dominates the market. The purpose of these injections is to relieve moderate to severe pain. It can also be used with an anesthetic before to or during surgery. Among the companies in this market are Duramorph, Infumorph, and Astramorph PF.
The market is divided into two categories based on application: Diarrhea Suppressant, Pain Management, Cold & Cough Suppressant and Others. The pain management sector dominates the market and is likely to maintain its dominance during the forecast period due to the widespread usage of morphine as a pain reliever. It can be used to treat or reduce pain from a variety of illnesses, including significant trauma from accidents, labor pain, cancer pain, and surgical pain.
Morphine Drugs Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period. The market is expected to expand more robustly in the presence of established players. Over the projection period, the growing prevalence of musculoskeletal disorders and the strong demand in the pharmaceutical industry are also anticipated to support the regional expansion. As to the April 2020 factsheet released by the Department of Justice and Drug Enforcement Administration, morphine derived from opium is utilized directly in medicinal goods within the United States. Consequently, the region's market demand may be driven over the projection period by the usage of morphine in the pharmaceutical industry.
Morphine Drugs Market- Competitive Landscape:
The market players operating in the Morphine Drugs market are Pfizer Inc., Mallinckrodt Pharmaceuticals, AbbVie Inc., Delpharm (Sandoz Canada Inc.), Dr. Reddy's Laboratories Ltd (Mayne Pharma Group Limited), Daiichi Sankyo Company Limited, Verve Health Care Ltd, Hikma Pharmaceuticals USA Inc., Sun Pharmaceutical Industries Ltd, Viatris Inc., Alcaliber S.A and Sanofi among others. These players adopted various strategies to hold a maximum market share such as product launches, acquisitions, expansion and others.
Recent Developments:
In July 2022, one lot of thirty milligram and one lot of sixty milligram extended-release morphine sulfate tablets (10 bottles each) were voluntarily recalled by Bryant Ranch Prepack Inc. from consumer distribution.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MORPHINE DRUGS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Pfizer Inc.
Mallinckrodt Pharmaceuticals
AbbVie Inc.
Delpharm (Sandoz Canada Inc.)
Dr. Reddy's Laboratories Ltd (Mayne Pharma Group Limited)
Daiichi Sankyo Company Limited
Verve Health Care Ltd
Hikma Pharmaceuticals USA Inc.
Sun Pharmaceutical Industries Ltd
Viatris Inc.
Alcaliber S.A
Sanofi
GLOBAL MORPHINE DRUGS MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019 - 2032
- Oral
- Injection
- Others
GLOBAL MORPHINE DRUGS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Diarrhea Suppressant
- Pain Management
- Cold & Cough Suppressant
- Others
GLOBAL MORPHINE DRUGS MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
GLOBAL MORPHINE DRUGS MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032
- Ambulatory Surgical Centers
- Hospitals & Clinics
- Others
GLOBAL MORPHINE DRUGS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV2233
Table of Contents
1. Morphine Drugs Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Morphine Drugs Market Snippet by Dosage Form
- 2.1.2. Morphine Drugs Market Snippet by Application
- 2.1.3. Morphine Drugs Market Snippet by Distribution Channel
- 2.1.4. Morphine Drugs Market Snippet by End Use
- 2.1.5. Morphine Drugs Market Snippet by Country
- 2.1.6. Morphine Drugs Market Snippet by Region
- 2.2. Competitive Insights
3. Morphine Drugs Key Market Trends
- 3.1. Morphine Drugs Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Morphine Drugs Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Morphine Drugs Market Opportunities
- 3.4. Morphine Drugs Market Future Trends
4. Morphine Drugs Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Morphine Drugs Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Morphine Drugs Market Landscape
- 6.1. Morphine Drugs Market Share Analysis, 2023
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Morphine Drugs Market - By Dosage Form
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Dosage Form, 2023 & 2032 (%)
- 7.1.2. Oral
- 7.1.3. Injection
- 7.1.4. Others
8. Morphine Drugs Market - By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 8.1.2. Diarrhea Suppressant
- 8.1.3. Pain Management
- 8.1.4. Cold & Cough Suppressant
- 8.1.5. Others
9. Morphine Drugs Market - By Distribution Channel
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
- 9.1.2. Hospital Pharmacies
- 9.1.3. Retail Pharmacies
- 9.1.4. Online Pharmacies
- 9.1.5. Others
10. Morphine Drugs Market - By End Use
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By End Use, 2023 & 2032 (%)
- 10.1.2. Ambulatory Surgical Centers
- 10.1.3. Hospitals & Clinics
- 10.1.4. Others
11. Morphine Drugs Market- By Geography
- 11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 11.2. North America
- 11.2.1. Overview
- 11.2.2. Morphine Drugs Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
- 11.2.8.1. Overview
- 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.8.3. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.2.8.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.8.5. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
- 11.2.9.1. Overview
- 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.9.3. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.2.9.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.9.5. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.2.9.6. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3. Europe
- 11.3.1. Overview
- 11.3.2. Morphine Drugs Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
- 11.3.8.1. Overview
- 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.8.3. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.3.8.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.8.5. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.8.6. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.9. Italy
- 11.3.9.1. Overview
- 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.9.3. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.9.5. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.9.6. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.10. United Kingdom
- 11.3.10.1. Overview
- 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.10.3. United Kingdom Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.10.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.10.6. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.11. France
- 11.3.11.1. Overview
- 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.11.3. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.11.5. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.11.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.12. Russia
- 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.12.2. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.3.12.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.12.4. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.12.5. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.13. Netherlands
- 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.13.2. Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.3.13.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.13.4. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.13.5. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
- 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.14.2. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.14.4. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.14.5. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.15. Poland
- 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.15.2. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.15.4. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.15.5. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.16. Rest of Europe
- 11.3.16.1. Overview
- 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.16.3. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.16.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.16.6. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Morphine Drugs Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.8. India
- 11.4.8.1. Overview
- 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.8.3. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.8.5. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.8.6. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.9. China
- 11.4.9.1. Overview
- 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.9.3. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.9.5. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.9.6. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
- 11.4.10.1. Overview
- 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.10.3. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.10.5. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.10.6. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
- 11.4.11.1. Overview
- 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.11.3. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.4.11.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.11.5. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.11.6. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
- 11.4.12.1. Overview
- 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.12.3. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.4.12.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.12.5. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.12.6. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.13. Thailand
- 11.4.13.1. Overview
- 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.13.3. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.13.5. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.13.6. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.14. Indonesia
- 11.4.14.1. Overview
- 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.14.3. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.14.5. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.14.6. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
- 11.4.15.1. Overview
- 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.15.3. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.4.15.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.15.5. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
- 11.4.16.1. Overview
- 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.16.3. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.16.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.5. Latin America
- 11.5.1. Overview
- 11.5.2. Morphine Drugs Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
- 11.5.8.1. Overview
- 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.8.3. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.5.8.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.8.5. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
- 11.5.9.1. Overview
- 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.9.3. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.5.9.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.9.5. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
- 11.5.10.1. Overview
- 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.10.3. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.5.10.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.10.5. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
- 11.5.11.1. Overview
- 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.11.3. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.5.11.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.11.5. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
- 11.5.12.1. Overview
- 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.12.3. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.12.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. Morphine Drugs Key Manufacturers in Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
- 11.6.8.1. Overview
- 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.8.3. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.8.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
- 11.6.9.1. Overview
- 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.9.3. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.9.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
- 11.6.10.1. Overview
- 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.10.3. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.6.10.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.10.5. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.6.10.6. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
- 11.6.11.1. Overview
- 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.11.3. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.6.11.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.11.5. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
- 11.6.12.1. Overview
- 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.12.3. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.6.12.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.12.5. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
- 11.6.13.1. Overview
- 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.13.3. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.6.13.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.13.5. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
- 11.6.14.1. Overview
- 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.14.3. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.14.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Morphine Drugs Industry
- 12.1. Competitive Dashboard
- 12.2. Company Profiles
- 12.2.1. Pfizer Inc.
- 12.2.2. Mallinckrodt Pharmaceuticals
- 12.2.3. AbbVie Inc.
- 12.2.4. Delpharm (Sandoz Canada Inc.)
- 12.2.5. Dr. Reddy's Laboratories Ltd (Mayne Pharma Group Limited)
- 12.2.6. Daiichi Sankyo Company Limited
- 12.2.7. Verve Health Care Ltd
- 12.2.8. Hikma Pharmaceuticals USA Inc.
- 12.2.9. Sun Pharmaceutical Industries Ltd
- 12.2.10. Viatris Inc.
- 12.2.11. Alcaliber S.A
- 12.2.12. Sanofi
13. 360 Degree Analyst View
14. Appendix
- 14.1. Research Methodology
- 14.2. References
- 14.3. Abbreviations
- 14.4. Disclaimer
- 14.5. Contact Us
Product Code: ANV2233
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Morphine Drugs Market: Dosage Form Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Dosage Form
- TABLE Global Morphine Drugs Market, by Dosage Form 2019-2032 (USD Million)
- TABLE Morphine Drugs Market: Application Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Application
- TABLE Global Morphine Drugs Market, by Application 2019-2032 (USD Million)
- TABLE Morphine Drugs Market: Distribution Channel Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
- TABLE Global Morphine Drugs Market, by Distribution Channel 2019-2032 (USD Million)
- TABLE Morphine Drugs Market: End Use Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by End Use
- TABLE Global Morphine Drugs Market, by End Use 2019-2032 (USD Million)
- TABLE Morphine Drugs Market: Regional snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Morphine Drugs Market, by Region 2019-2032 (USD Million)
- TABLE North America Morphine Drugs Market, by Country, 2019-2032 (USD Million)
- TABLE North America Morphine Drugs Market, by Dosage Form, 2019-2032 (USD Million)
- TABLE North America Morphine Drugs Market, by Application, 2019-2032 (USD Million)
- TABLE North America Morphine Drugs Market, by Distribution Channel, 2019-2032 (USD Million)
- TABLE North America Morphine Drugs Market, by End Use, 2019-2032 (USD Million)
- TABLE Europe Morphine Drugs Market, by Country, 2019-2032 (USD Million)
- TABLE Europe Morphine Drugs Market, by Dosage Form, 2019-2032 (USD Million)
- TABLE Europe Morphine Drugs Market, by Application, 2019-2032 (USD Million)
- TABLE Europe Morphine Drugs Market, by Distribution Channel, 2019-2032 (USD Million)
- TABLE Europe Morphine Drugs Market, by End Use, 2019-2032 (USD Million)
- TABLE Asia Pacific Morphine Drugs Market, by Country, 2019-2032 (USD Million)
- TABLE Asia Pacific Morphine Drugs Market, by Dosage Form, 2019-2032 (USD Million)
- TABLE Asia Pacific Morphine Drugs Market, by Application, 2019-2032 (USD Million)
- TABLE Asia Pacific Morphine Drugs Market, by Distribution Channel, 2019-2032 (USD Million)
- TABLE Asia Pacific Morphine Drugs Market, by End Use, 2019-2032 (USD Million)
- TABLE Latin America Morphine Drugs Market, by Country, 2019-2032 (USD Million)
- TABLE Latin America Morphine Drugs Market, by Dosage Form, 2019-2032 (USD Million)
- TABLE Latin America Morphine Drugs Market, by Application, 2019-2032 (USD Million)
- TABLE Latin America Morphine Drugs Market, by Distribution Channel, 2019-2032 (USD Million)
- TABLE Latin America Morphine Drugs Market, by End Use, 2019-2032 (USD Million)
- TABLE Middle East and Africa Morphine Drugs Market, by Country, 2019-2032 (USD Million)
- TABLE Middle East and Africa Morphine Drugs Market, by Dosage Form, 2019-2032 (USD Million)
- TABLE Middle East and Africa Morphine Drugs Market, by Application, 2019-2032 (USD Million)
- TABLE Middle East and Africa Morphine Drugs Market, by Distribution Channel, 2019-2032 (USD Million)
- TABLE Middle East and Africa Morphine Drugs Market, by End Use, 2019-2032 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.